Growth Hormone Secretagogues
Hexarelin
A synthetic growth hormone-releasing hexapeptide studied in small human endocrine-response experiments; it has no FDA-approved indication.
- Investigational
- Ghrelin Receptor
- Human Studies
- WADA Prohibited
Educational evidence summaries. No dosing, sourcing, or treatment instructions.
Identity, receptor pathway, human evidence, safety context, approval history, and unresolved questions.
A synthetic growth hormone-releasing hexapeptide studied in small human endocrine-response experiments; it has no FDA-approved indication.
A short-acting modified GHRH (1-29) analogue commonly marketed as CJC-1295 no DAC; distinct from albumin-binding CJC-1295 with DAC.